Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.14064DOI Listing

Publication Analysis

Top Keywords

brazilian version
4
version breast-q
4
breast-q -breast-conserving
4
-breast-conserving therapy
4
therapy module
4
module translation
4
translation cross-cultural
4
cross-cultural adaptation
4
adaptation reproducibility
4
brazilian
1

Similar Publications

: Yellow fever virus (YFV) (, ) is the etiologic agent of yellow fever (YF), a vector-borne disease with significant morbidity and mortality across the tropics and neotropics, despite having a highly efficacious and safe vaccine (17D). Vaccination provides lifelong protection from YF disease mediated by humoral immunity. There are several versions of the original 17D vaccine: 17D-204 (marketed in the USA as YF-VAX, in France as Stamaril, and in China as Tiantan-V), 17D-213 (Russian Federation), and 17DD (by FIOCRUZ in Brazil).

View Article and Find Full Text PDF
Article Synopsis
  • Access to healthcare for individuals experiencing long COVID in the Brazilian Amazon is limited, with only 45.88% of participants receiving treatment.
  • The study involved 364 participants who had COVID-19 and later developed long COVID, analyzed through an online survey and multiple logistic regression.
  • The factors linked to better access to healthcare included specific symptoms like skin issues, a pre-existing chronic disease diagnosis, treatment by healthcare professionals during COVID-19, and the use of antibiotics, indicating a need for targeted services.
View Article and Find Full Text PDF

Psychometric properties of the Global Psychotrauma Screen (GPS) in the Brazilian general population.

Trends Psychiatry Psychother

January 2024

Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Public Health Research Institute and Amsterdam Neuroscience Research Institute, Amsterdam, Netherlands. ARQ National Psychotrauma Centre, Diemen, Netherlands.

Article Synopsis
  • The study aimed to assess the psychometric properties of the Brazilian version of the Global Psychotrauma Screen (GPS).
  • Two internet-based samples were analyzed: one for exploratory factor analysis (EFA) and the other for confirmatory factor analysis (CFA) alongside other analyses.
  • Results indicated that the GPS effectively identifies probable PTSD and related symptoms, validating its use as a screening tool for posttraumatic reactions in Brazil.
View Article and Find Full Text PDF

Addressing the needs for cultural adaptation of DARE-keepin' it REAL among Brazilian students: strategies to improve implementation.

Subst Abuse Treat Prev Policy

December 2024

Department of Preventive Medicine, Universidade Federal de São Paulo, Rua Botucatu, N 740 - Vila Clementino, São Paulo, SP, 04023-062, Brazil.

Background: The widely implemented prevention program in Brazil, PROERD (a translated version of the DARE-kiR program), showed no evidence of effect in preventing drug use in a recent trial. The lack of cultural adaptation and instructors' deviations from the curriculum were identified as potential reasons for its ineffectiveness. This study aims to identify points of inadequacy of the PROERD program for the Brazilian culture, suggesting strategies for revising the curriculum to improve implementation.

View Article and Find Full Text PDF

Objectives: The aim of this study was to adapt and apply the Portuguese version of the Transgender Man Voice Questionnaire in a sample of Brazilian transgender men and to investigate the relationship between voice satisfaction and hormone therapy duration. In addition, we suggest reducing and reformulating the questionnaire for screening.

Methods: We conducted a cross-sectional study of 31 transgender men aged 18-50 years undergoing hormone therapy who answered a questionnaire adapted from the Transgender Woman Voice Questionnaire, validated in Portuguese.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!